NCT04669366View on ClinicalTrials.gov

Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

CompletedOBSERVATIONAL
Enrollment

1,205

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

July 31, 2021

Study Completion Date

March 18, 2022

Conditions
Kidney Neoplasms
Interventions
DRUG

sunitinib

As provided in real world

DRUG

axitinib

As provided in real world

Trial Locations (1)

19190

Pfizer Innovations AB, Sollentuna

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04669366 - Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries | Biotech Hunter | Biotech Hunter